Behaviorally selective effects of neuroactive steroids on plus-maze anxiety in mice

Pharmacology Biochemistry and Behavior

Volumn 59, Issue 1, 1998, Pages 221-232

  Rodgers, R J ^a   Johnson, N J T ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Anxiety; Behavioral selectivity; Diazepam Mice; Neuroactive steroids; Plus maze

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 3ALPHA,21 DIHYDROXY 5ALPHA PREGNAN 20 ONE; 3BETA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; 5ALPHA PREGNANE 3,20 DIONE; DIAZEPAM; ELTANOLONE; PREGNANEDIONE; STEROID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; STEROID ANALYSIS; TRANQUILIZING ACTIVITY;

5-ALPHA-DIHYDROPROGESTERONE; ANIMALS; ANTI-ANXIETY AGENTS; DESOXYCORTICOSTERONE; DIAZEPAM; MALE; MAZE LEARNING; MICE; MICE, INBRED DBA; PREGNANEDIONES; PREGNANOLONE; STEROIDS;

ANIMALIA; RODENTIA;

EID: 0031973457     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00339-0     Document Type: Article

References (54)

1. Auta, J.; Romeo, E.; Kozikowski, A.; Ma, D.; Costa, E.; Guidotti, A.: Participation of mitochondrial diazepam binding inhibitor receptors in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3-indoleacetamide and imidazopyridine derivatives. J. Pharmacol. Exp. Ther. 265:649-656; 1993.
2. Barbaccia M. L., Roscetti G., Bolacchi F., Concas A., Mostallino M. C., Purdy R. H., Biggio G. Stress-induced increase in brain neuroactive steroids. Antagonism by abecarnil Pharmacol. Biochem. Behav. 54:1996;205-210.
3. 2 inhalation Eur. J. Pharmacol. 261:1994;317-320.
4. A receptor Brain Res. 561:1991;157-161.
5. Blanchard D. C., Blanchard R. J., Tom P., Rodgers R. J. Diazepam changes risk assessment in an anxiety-defense test battery. Psychopharmacology (Berlin). 101:1990;511-518.
6. Budziszewska B., Jaworska-Feil L., Lason W. Neurosteroids and the naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Eur. Neuropsychopharmacol. 6:1996;135-140.
7. Chen S.-W., Rodriquez L., Davies M. F., Loew G. H. The hyperphagic effect of 3α-hydroxylated steroids in male rats. Pharmacol. Biochem. Behav. 53:1996;777-782.
8. Cole J.C., Rodgers R. J. An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro16-6028) in the murine elevated plus-maze. Behav. Pharmacol. 4:1993;573-580.
9. Cole J. C., Rodgers R. J. Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze. Pharmacol. Biochem. Behav. 52:1995;473-478.
10. 35S]-TBPS binding in the brain of rats exposed to isoniazid, pentylenetetrazol or stress. Br. J. Pharmacol. 118:1996;839-846.
11. Crawley J. N., Glowa J. R., Majewska M. D., Paul S. M. Anxiolytic activity of an endogenous adrenal steroid. Brain Res. 398:1986;382-385.
12. Cruz A. P. M., Frei F., Graeff F. G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 49:1994;171-176.
13. Dalvi A., Rodgers R. J. GABAergic influences on plus-maze behaviour in mice. Psychopharmacology (Berlin). 128:1996;380-397.
14. Dazzi L., Sanna A., Cagetti E., Concas A., Biggio G. Inhibition by the neurosteroid allopregnanolone of basal and stress-induced acetylcholine release in the brain of freely moving rats. Brain Res. 710:1996;275-280.
15. A receptors to neurosteroids in rats during ethanol withdrawal. J. Pharmacol. Exp. Ther. 278:1996;510-517.
16. Fernandes C., File S. E. The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol. Biochem. Behav. 54:1996;31-40.
17. File S. E. Behavioural detection of anxiolytic action. Elliott J. H., Heal D. J., Marsden C. A. Experimental approaches to anxiety and depression. 1992;25-44 Wiley, Chichester.
18. Finn D. A., Roberts A. J., Crabbe J. C. Neuroactive steroid sensitivity in withdrawal seizure-prone and -resistant mice. Alcohol. Clin. Exp. Res. 19:1995;410-415.
19. Frye C. A., Duncan J. E. Progesterone metabolites, effective at the GABA-A receptor complex, attenuate pain sensitivity in rats. Brain Res. 643:1994;194-303.
20. 1) selective, benzodiazepine receptor ligands. Psychopharmacology (Berlin). 124:1996;245-254.
21. Grobin A. C., Roth R. H., Deutch A. Y. Regulation of the prefrontal cortical dopamine system by the neuroactive steroid 3α, 21-dihydroxy-5α-pegnane-20-one. Brain Res. 578:1992;351-356.
22. Harrison N. L., Simmonds M. A. Modulation of the GABA receptor complex by a steroid anesthetic. Brain Res. 323:1984;287-292.
23. B) receptor ligands in the elevated plus-maze test of anxiety in mice. Psychopharmacology (Berlin). 124:1996;355-364.
24. Kavaliers M. Inhibitory influences of the adrenal steroid, 3α, 5α-tetrahydrodeoxycorticosterone, on aggression and defeat-induced analgesia in mice. Psychopharmacology (Berlin). 95:1988;488-492.
25. Kavaliers M., Wiebe J. P., Galea L. A. M. Male preference for the odors of estrous female mice is enhanced by the neurosteroid 3α-hydroxy-4-pregnan-20-one (3α-HP). Brain Res. 646:1995;140-144.
26. A receptor function. Trends Pharmacol. Sci. 16:1995;295-303.
27. A receptor. Horm. Behav. 28:1994;537-544.
28. A receptor modulators. Am. J. Physiol. 271:1996;E763-E772.
29. Lister R. G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berlin). 92:1987;180-185.
30. A receptor. Mechanism of action and physiological significance Prog. Neurobiol. 38:1992;379-395.
31. Majewska M. D., Harrison N. L., Schwartz R. D., Barker J. L., Paul S. M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 232:1986;1004-1007.
32. McCreary A. C., McBlane J. W., Spooner H. A., Handley S. L. 5-HT systems and anxiety. Multiple mechanisms in the elevated X-maze Pol. J. Pharmacol. 48:1996;1-12.
33. McEwen B. S. Nongenomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci. 12:1991;141-147.
34. Melchior C. L., Ritzmann R. F. Neurosteroids block the memory-impairing effects of ethanol in mice. Pharmacol. Biochem. Behav. 53:1995;51-56.
35. Mendelson W. B., Martin J. V., Perlis M., Wagner R., Majewska M. D., Paul S. M. Sleep induction by an adrenal steroid in the rat. Psychopharmacology (Berlin). 93:1987;226-229.
36. Molewijk H. E., van der Poel A. M., Olivier B. The ambivalent behaviour 'stretched attend posture' in the rat as a paradigm to characterize anxiolytic drugs. Psychopharmacology (Berlin). 121:1995;81-90.
37. Morrow A. L., Suzdak P. D., Paul S. M. Steroid hormone metabolites potentiate GABA receptor-mediated chloride-ion flux with nanomolar potency. Eur. J. Pharmacol. 142:1987;483-485.
38. Motzo C., Porceddu M. L., Maira G., Flore G., Concas A., Dazzi L., Biggio G. Inhibition of basal and stress-induced dopamine release in the cerebral cortex and nucleus accumbens of freely moving rats by the neurosteroid allopregnanolone. J. Psychopharmcol. 10:1996;266-272.
39. A receptors and anxiety. From neurobiology to treatment:1995;57-74 Raven Press, New York.
40. Owens M. J., Ritchie J. C., Nemeroff C. B. 5α-Pregnane-3α,21-diol-20-one (THDOC) attenuates mild stress-induced increases in plasma corticosterone via a nonglucocorticoid mechanism. Comparison with alprazolam Brain Res. 573:1992;353-355.
41. Paul S. M., Purdy R. H. Neuroactive steroids. FASEB J. 6:1992;2311-2322.
42. Picazo O., Fernandez-Guasti A. Anti-anxiety effects of progesterone and some of its reduced metabolites. An evaluation using the burying behavior test Brain Res. 680:1995;135-141.
43. Robel P., Baulieu E.-E. Neurosteroids. Biosynthesis and function. Trends Endocrinol. Metab. 5:1994;1-8.
44. Rodgers R. J., Cao B.-J., Dalvi A., Holmes A. Animal models of anxiety. An ethological perspective Braz. J. Med. Biol. Res. 30:1997;289-304.
45. Rodgers R. J., Cole J. C. The elevated plus-maze. Pharmacology, methodology and ethology In. Cooper, S. J.; Hendrie, C. A., eds. Ethology and psychopharmacology. Chichester: Wiley; 9-44:1994.
46. Rodgers R. J., Johnson N. J. T. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze. Pharmacol. Biochem. Behav. 52:1995;297-303.
47. Rodgers R. J., Shepherd J. K. Effects of an endogenous anxiolytic adrenal steroid, alpha-THDOC, on nonopioid defeat analgesia in male mice. Interaction with Ro15-1788 J. Psychopharmacol. 2:1988;150-158.
48. Rupprecht R., Hauser C. A. E., Trapp T., Holsboer F. Neurosteroids. Molecular mechanisms of action and psychopharmacological significance J. Steroid Biochem. Mol. Biol. 56:1996;163-168.
49. Seyle H. The anesthetic effect of steroid hormones. Proc. Soc. Exp. Biol. Med. 46:1941;116-121.
50. Shepherd J. K., Grewal S. S., Fletcher A., Bill D. J., Dourish C. T. Behavioural and pharmacological characterization of the elevated zero-maze as an animal model of anxiety. Psychopharmacology (Berlin). 124:1994;245-254.
51. Treit D., Menard J., Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol. Biochem. Behav. 44:1993;463-469.
52. Wieland S., Belluzzi J. D., Stein L., Lan N. C. Comparative behavioral characterization of the neuroactive steroids 3α-OH-5α-pregnan-20-one and 3α-OH, 5β-pregnan-20-one in rodents. Psychopharmacology (Berlin). 118:1995;65-71.
53. Wieland S., Lan N. C., Mirasedegi S., Gee K. W. Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Brain Res. 565:1991;263-268.
54. Zimmerberg B., Brunelli S. A., Hofer M. A. Reduction of rat pup ultrasonic vocalizations by the neuroctive steroid allopregnanolone. Pharmacol. Biochem. Behav. 47:1994;735-738.